1-(Difluoromethyl)cyclopropane-1-carboxylic acid, 97%, 5g

tert-Butyl 5'-bromo-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-carboxylate, 95.0%, 1g

Lac beta(1-4)Lac-beta-C10>98.0%(HPLC)100mg

4-Chloro-1H-indazole, 97.0%, 25g

5-[(4-bromophenyl)methyl]-1H-1,2,3,4-tetrazole, 95%, 1g

N~1~-(3-aminophenyl)-N~2~,N~2~-dimethylglycinamide dihydrochloride, 95.0%, 1g

8-Chloroimidazo[1,2-a]pyrazine-2-carboxylic acid, 97%, 100mg

2-(1-Naphthylene)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Recipiente de cristalización DURAN® con pico, 500 ml, 115 mm, 1 Pieza

6-bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine, 100mg

(2E)-3-{2-[acetyl(phenyl)amino]-1,3-thiazol-4-yl}acrylic acid, 100mg

2,3,5-Tri-O-benzyl-D-ribose, 95.0%, 10g

4-[5-Bromo-6-chloro-4-(trifluoromethyl)pyridin-2-yl]morpholine, 95.0%, 1g